Download PDF
Exp Clin Endocrinol Diabetes 2011; 119(08): 457-458
DOI: 10.1055/s-0031-1284338
Letter to the Editor
Georg Thieme Verlag KG Stuttgart · New York

Apelin, Prediabetes and Atherosclerosis

I. Tasci
1   Department of Internal Medicine, Gulhane School of Medicine, Turkey
› Author Affiliations
Further Information

Publication History

Publication Date:
02 August 2011 (online)

Also available at
    Permissions and Reprints
 

  • References

  • 1 Bots ML, Westerink J, Rabelink TJ et al. Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response. Eur Heart J 2005; 26: 363-368
    CrossrefPubMedGoogle Scholar
  • 2 Erdem G, Dogru T, Tasci I et al. Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2008; 116: 289-292
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Graham I, Atar D, Borch-Johnsen K et al. European Society of Cardiology (ESC); European Association for Cardiovascular Prevention and Rehabilitation (EACPR); Council on Cardiovascular Nursing; European Association for Study of Diabetes (EASD); International Diabetes Federation Europe (IDF-Europe); European Stroke Initiative (EUSI); International Society of Behavioural Medicine (ISBM); European Society of Hypertension (ESH); European Society of General Practice/Family Medicine (ESGP/FM/WONCA); European Heart Network (EHN). European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007; 14 (Suppl. 02) E1-E40
    CrossrefPubMedGoogle Scholar
  • 4 Lucio M, Fekete A, Weigert C et al. Insulin sensitivity is reflected by characteristic metabolic fingerprints – a Fourier transform mass spectrometric non-targeted metabolomics approach. PLoS One 2010; 5: e13317
    CrossrefPubMedGoogle Scholar
  • 5 Radikova Z, Koska J, Huckova M et al. Insulin sensitivity indices: a proposal of cut-off points for simple identification of insulin-resistant subjects. Exp Clin Endocrinol Diabetes 2006; 114: 249-256
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Ringström C, Nitert MD, Bennet H et al. Apelin is a novel islet peptide. Regul Pept 2010; 162: 44-51
    CrossrefPubMedGoogle Scholar
  • 7 Rittig K, Hildebrandt U, Thamer C et al. Apelin Serum Levels are not Associated with Early Atherosclerosis or Fat Distribution in Young Subjects with Increased Risk for Type 2 Diabetes. Exp Clin Endocrinol Diabetes 2011; DOI: http://dx.doi.org/10.1055/s-0030-1268466.
    PubMedGoogle Scholar
  • 8 Sonmez A, Celebi G, Erdem G et al. Plasma apelin and ADMA Levels in patients with essential hypertension. Clin Exp Hypertens 2010; 32: 179-183
    CrossrefPubMedGoogle Scholar
  • 9 Tasci I, Dogru T, Naharci I et al. Plasma apelin is lower in patients with elevated LDL-cholesterol. Exp Clin Endocrinol Diabetes 2007; 115: 428-432
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Zhang Y, Shen C, Li X et al. Low plasma apelin in newly diagnosed type 2 diabetes in Chinese people. Diabetes Care 2009; 32: e150
    CrossrefPubMedGoogle Scholar